156 related articles for article (PubMed ID: 25533581)
21. Sustained reductions in time to antibiotic delivery in febrile immunocompromised children: results of a quality improvement collaborative.
Dandoy CE; Hariharan S; Weiss B; Demmel K; Timm N; Chiarenzelli J; Dewald MK; Kennebeck S; Langworthy S; Pomales J; Rineair S; Sandfoss E; Volz-Noe P; Nagarajan R; Alessandrini E
BMJ Qual Saf; 2016 Feb; 25(2):100-9. PubMed ID: 26341714
[TBL] [Abstract][Full Text] [Related]
22. Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.
Baltic T; Schlosser E; Bedell MK
Clin J Oncol Nurs; 2002; 6(6):337-40. PubMed ID: 12434465
[TBL] [Abstract][Full Text] [Related]
23. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.
Green AL; Yi J; Bezler N; Pikman Y; Tubman VN; Obeng EA; O'Neil T; Mersereau R; Morrissey L; Billett AL
Pediatr Blood Cancer; 2016 Jan; 63(1):112-7. PubMed ID: 26292080
[TBL] [Abstract][Full Text] [Related]
24. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
[TBL] [Abstract][Full Text] [Related]
25. A nurse-led protocol improves the time to first dose intravenous antibiotics in septic patients post chemotherapy.
Mattison G; Bilney M; Haji-Michael P; Cooksley T
Support Care Cancer; 2016 Dec; 24(12):5001-5005. PubMed ID: 27455849
[TBL] [Abstract][Full Text] [Related]
26. Addressing the barriers to optimal management of febrile neutropenia in children with cancer.
Anderson K; Bradford N; Edwards R; Nicholson J; Lockwood L; Clark J
Eur J Oncol Nurs; 2020 Apr; 45():101719. PubMed ID: 32163859
[TBL] [Abstract][Full Text] [Related]
27. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
28. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?
Wierema J; Konecny P; Links M
Intern Med J; 2013 Oct; 43(10):1116-24. PubMed ID: 23869563
[TBL] [Abstract][Full Text] [Related]
29. Optimal Management of Neutropenic Fever in Patients With Cancer.
Zimmer AJ; Freifeld AG
J Oncol Pract; 2019 Jan; 15(1):19-24. PubMed ID: 30629902
[TBL] [Abstract][Full Text] [Related]
30. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
31. Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement Intervention.
Yoshida H; Leger KJ; Xu M; Migita RT; Rutledge JC; Pollard JA; Kroon L; Mazor SS; Moon A; Rutman LE
Pediatr Emerg Care; 2018 Jan; 34(1):47-52. PubMed ID: 29293201
[TBL] [Abstract][Full Text] [Related]
32. FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.
Assefa S; Alemayehu T; Abebe W
Ethiop Med J; 2017 Jan; 55(1):43-7. PubMed ID: 29148638
[TBL] [Abstract][Full Text] [Related]
33. Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?
Baugh CW; Wang TJ; Caterino JM; Baker ON; Brooks GA; Reust AC; Pallin DJ
Acad Emerg Med; 2017 Jan; 24(1):83-91. PubMed ID: 27611638
[TBL] [Abstract][Full Text] [Related]
34. Improving hospital performance in the treatment of febrile neutropenia.
Meisenberg B; Clemons J; Ness J; Faust N; Clance M
Support Care Cancer; 2015 Feb; 23(2):371-5. PubMed ID: 25103678
[TBL] [Abstract][Full Text] [Related]
35. Retrospective audit of neutropenic fever after chemotherapy: how many patients could benefit from oral antibiotic management?
Poprawski DM; Chan J; Barnes A; Koczwara B
Intern Med J; 2018 Dec; 48(12):1533-1535. PubMed ID: 30517995
[TBL] [Abstract][Full Text] [Related]
36. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
[TBL] [Abstract][Full Text] [Related]
37. Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles.
Geerlinks AV; Digout C; Bernstein M; Chan A; MacPhee S; Pambrun C; Gallant G; Wyatt L; Fernandez CV; Price VE
Pediatr Emerg Care; 2020 Nov; 36(11):509-514. PubMed ID: 33125202
[TBL] [Abstract][Full Text] [Related]
38. Clinical practice guidelines for children with cancer presenting with fever to the emergency room.
Pakakasama S; Surayuthpreecha K; Pandee U; Anurathapan U; Maleewan V; Udomsubpayakul U; Butthep P; Santanirand P; Sirachainan N; Hongeng S
Pediatr Int; 2011 Dec; 53(6):902-5. PubMed ID: 21418423
[TBL] [Abstract][Full Text] [Related]
39. The signs, symptoms and help-seeking experiences of neutropenic sepsis patients before they reach hospital: a qualitative study.
Clarke RT; Bird S; Kakuchi I; Littlewood TJ; van Hamel Parsons V
Support Care Cancer; 2015 Sep; 23(9):2687-94. PubMed ID: 25663575
[TBL] [Abstract][Full Text] [Related]
40. Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.
Braga CC; Taplitz RA; Flowers CR
J Oncol Pract; 2019 Jan; 15(1):25-26. PubMed ID: 30629901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
